Loading...
XIDX
PRDA
Market cap121mUSD
Nov 12, Last price  
2,470.00IDR
Name

Prodia Widyahusada Tbk PT

Chart & Performance

D1W1MN
XIDX:PRDA chart
P/E
10.63
P/S
0.96
EPS
232.40
Div Yield, %
6.72%
Shrs. gr., 5y
-0.59%
Rev. gr., 5y
4.02%
Revenues
2.28t
+1.31%
997,986,700,0791,101,043,712,6121,197,727,222,0121,358,664,085,9761,466,017,000,0001,599,757,000,0001,744,271,000,0001,873,375,000,0002,652,257,000,0002,181,642,000,0002,222,466,000,0002,252,194,000,0002,281,704,000,000
Net income
206.79b
-23.47%
61,590,631,71358,560,231,45559,024,994,42288,134,987,526150,797,000,000175,450,000,000210,261,000,000268,747,000,000623,230,000,000371,647,000,000259,874,000,000270,197,000,000206,788,000,000
CFO
424.13b
-11.02%
82,664,729,507105,658,756,890155,608,151,085119,253,694,64093,470,000,000239,829,000,000341,825,000,000434,631,000,000777,266,000,000496,733,000,000411,285,000,000476,645,000,000424,134,000,000
Dividend
May 08, 2025172.92627 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.
URL
http://www.prodia.co.id/
IPO date
Dec 07, 2016
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT